Quantcast
Channel: MassDevice
Browsing all 12024 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for March 16, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article


Image may be NSFW.
Clik here to view.

Decision Diagnostics sues J&J’s LifeScan over glucose test strip patents

Decision Diagnostics (OTC:DECN) said today its subsidiaries Decision IT and Pharma Tech Solutions filed a lawsuit against Johnson & Johnson (NYSE:JNJ) and its Lifescan divisions over patent...

View Article


Image may be NSFW.
Clik here to view.

InspireMD opens $1.7 million in offerings to support embolic tech

InspireMD (OTC:NSPR) said today it is opening an underwritten public offering looking to bring in approximately $1.1 million through the sale of 1.9 million shares to support its CGuard EPS and MGuard...

View Article

Image may be NSFW.
Clik here to view.

Vycor launches VBASMini brain access site

Vycor Medical (OTC:VYCO) said today it launched the VBASMini, a next-generation, smaller version of its ViewSite Surgical Access System, which are designed to provide surgeons access to brain tissue...

View Article

Image may be NSFW.
Clik here to view.

A ‘roadmap’ for navigating patient advocacy

By: John J. Whyte, M.D., M.P.H. So, you and your organization have a passion for helping people and you want to work with FDA to advance your advocacy work. Are you unsure of the most effective way to...

View Article


Image may be NSFW.
Clik here to view.

FDA: US medical device inspections down in 2015

The FDA said this week that it inspected fewer U.S. medical device plants last year than in 2014, but sent inspectors to more overseas facilities. The overall number of quality systems inspections fell...

View Article

Image may be NSFW.
Clik here to view.

Senseonics cuts IPO by 25% to $45m

Senseonics (OTC:SENH) today cut the value of a pending public offering by 25%, to $45 million, saying it plans to float fewer shares at a lower price. Germantown, Md.-based Senseonics had planned to...

View Article

Image may be NSFW.
Clik here to view.

Gecko Biomedical lands $25m for next-gen medical polymer

Gecko Biomedical said today that it raised a $25 million Series A2 round for the next-generation medical polymer it’s developing. Paris-based Gecko said the €22.5 million round was led by Sofinnova...

View Article


Image may be NSFW.
Clik here to view.

CorMatrix launches U.S. tricuspid valve device trial

CorMatrix Cardiovascular said today it enrolled the 1st patient in a trial of its CorMatrix ECM tricuspid valve designed from regenerative tissue. The early feasibility trial aims to demonstrate proof...

View Article


Image may be NSFW.
Clik here to view.

NuVasive nets $634m from convertible notes offering

NuVasive Inc. (NSDQ:NUVA) yesterday said it pulled down $634 million from a convertible debt offering it plans to use to buy back other notes coming due next year. San Diego-based NuVasive said the...

View Article

Image may be NSFW.
Clik here to view.

Zimmer Biomet lands $381m DoD ortho contract

The U.S. Department of Defense said it awarded Zimmer Biomet (NYSE:ZBH) a maximum $381 million fixed-price contract for various orthopedic products. The 1-year, indefinite-delivery/indefinite-quantity...

View Article

Image may be NSFW.
Clik here to view.

Appeals court upholds Abbott’s win in ex-employee’s retaliation suit

A federal appeals court yesterday upheld a lower court’s ruling on the validity of a hand-written agreement between a former employee who brought discrimination and retaliation charges against Abbott...

View Article

Image may be NSFW.
Clik here to view.

Baxter to further trim stake in Baxalta ahead of $32B Shire buyout

Baxter (NYSE:BAX) plans to further trim its stake in Baxalta (NYSE:BXLT), the biopharm business it spun out last year, reducing its ownership to 5.1% ahead of Baxalta’s $32 billion takeover by Shire...

View Article


Image may be NSFW.
Clik here to view.

Inovio Pharma picks up Bioject

Inovio Pharmaceuticals said today it paid $5.5 million for the assets of Bioject Medical Technologies including its needle-free jet injection tech, devices and intellectual property With the...

View Article

Image may be NSFW.
Clik here to view.

Jury slaps Johnson & Johnson with $500m verdict in Pinnacle hip bellwether

A Texas federal jury today slapped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics with a $500 million judgment in favor of a quintet of plaintiffs who said the metal-on-metal Pinnacle...

View Article


Image may be NSFW.
Clik here to view.

Osiris wins positive review from BCBSA for Grafix

Osiris Therapeutics said today the Blue Cross Blue Shield Association gave the company’s Grafix a positive review when used to treat individuals with diabetic lower-extremity ulcers. Gravix is a...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for March 17, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article


Image may be NSFW.
Clik here to view.

SRS Medical wins Korean clearance for Spanner stent

SRS Medical Systems said it won approval from South Korea’s Korea Food and Drug Administration for its Spanner temporary prostatic stent designed to be used as both an indwelling Foley catheter and an...

View Article

Image may be NSFW.
Clik here to view.

Physio-Control recalls AED electrodes made by by 3rd party

Physio-Control issued an urgent field safety notice recalling certain lots of its Quik-Combo adult pacing/defibrillation/ECG electrodes and its Red-Pak preconnected system due to a potential for damage...

View Article

Image may be NSFW.
Clik here to view.

FDA updates on Teleflex’s Class I Arrow intra-aortic balloon recall

The FDA today labeled Teleflex‘s (NYSE:TFX) recall of Arrow intra-aortic balloon cath and percutaneous insertion kits as a Class I recall. Class I recall designations, the agency’s most serious...

View Article
Browsing all 12024 articles
Browse latest View live